ADMA · Adma Biologics, Inc. · Documents
$11.00
+0.05 (+0.46%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$2.43B
Shares
223.98M
Volume · Oct 22
3.55M
Avg daily vol (3M)
2.67M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-02-21 | — | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-12-18 | — | |
| 8-K | — | 2023-12-12 | — | |
| 8-K | — | 2023-11-16 | — | |
| 10-Q | — | 2023-11-08 | 2023-09-30 | |
| 8-K | — | 2023-11-08 | — | |
| 8-K | — | 2023-10-02 | 2023-09-28 | |
| 8-K | — | 2023-08-09 | — | |
| 10-Q | — | 2023-08-09 | 2023-06-30 | |
| 8-K | — | 2023-07-19 | — | |
| 8-K | — | 2023-06-06 | — | |
| 8-K | — | 2023-05-22 | — | |
| 10-Q | — | 2023-05-10 | 2023-03-31 | |
| 8-K | — | 2023-05-10 | — | |
| 8-K | — | 2023-05-02 | 2023-05-01 | |
| DEF 14A | — | 2023-04-13 | 2023-06-06 | |
| 8-K | — | 2023-03-23 | — | |
| 10-K | — | 2023-03-23 | 2022-12-31 | |
| 8-K | — | 2023-03-10 | 2023-03-06 | |
| 8-K | — | 2023-02-08 | — | |
| 8-K | — | 2023-01-17 | — | |
| 8-K | — | 2022-12-09 | — | |
| 8-K | — | 2022-12-07 | — | |
| 8-K | — | 2022-12-06 | — | |
| 8-K | — | 2022-11-09 | — | |
| 10-Q | — | 2022-11-09 | 2022-09-30 | |
| 8-K | — | 2022-10-31 | — | |
| 8-K | — | 2022-08-10 | — | |
| 10-Q | — | 2022-08-10 | 2022-06-30 | |
| 8-K | — | 2022-06-27 | — | |
| 8-K | — | 2022-06-21 | — | |
| 8-K | — | 2022-06-13 | — | |
| 8-K | — | 2022-05-11 | — | |
| 10-Q | — | 2022-05-11 | 2022-03-31 | |
| DEF 14A | — | 2022-04-28 | 2022-06-21 | |
| 8-K | — | 2022-03-25 | — | |
| 10-K | — | 2022-03-24 | 2021-12-31 | |
| 8-K | — | 2022-03-24 | — | |
| 8-K | — | 2022-03-09 | 2022-03-07 | |
| 8-K | — | 2022-03-07 | — | |
| 8-K | — | 2022-01-19 | — | |
| 8-K | — | 2022-01-18 | — | |
| 8-K | — | 2021-12-21 | 2021-12-20 | |
| 8-K | — | 2021-12-09 | — | |
| 8-K | — | 2021-12-01 | — | |
| 8-K | — | 2021-11-16 | — | |
| 10-Q | — | 2021-11-10 | 2021-09-30 | |
| 8-K | — | 2021-11-10 | — |
Showing 51–100 of 157 filings
Key facts
CIK
1368514
CUSIP
000899104
13F (30d)
50 filings
50 filers
Visit website
Investor relations